Symbol | Exchange | Currency |
|---|
Denison Mines (DNN) acknowledged Uranium Participation ((UPC)) and Sprott Asset Management reaching an agreement for converting UPCinto the Sprott Physical Uranium Trust thereby...
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of...
It shouldn’t be so surprising now after months of huge moves in the market, but March was another stellar month for my day trading accounts. My net profits for the month came in...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Sell | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,288.92 | 2,289.78 | 2,255.51 | +10.54 | +0.46% | 1.08M | NASDAQ | |||
| 315.46 | 315.68 | 311.58 | -0.48 | -0.15% | 15.40M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 0.5045 | 0.00 | 0.00 | +0.0025 | +0.50% | 1.21M | NYSE | |||
| 18.76 | 19.84 | 18.55 | -1.130 | -5.68% | 12.47K | NASDAQ | |||
| 8.26 | 8.34 | 7.79 | +0.48 | +6.17% | 24.97M | NYSE | |||
| 1.15 | 1.19 | 1.1299 | +0.0100 | +0.88% | 11.38M | NYSE | |||
| 17.38 | 17.58 | 16.14 | +1.38 | +8.62% | 9.17M | NYSE | |||
| 73.25 | 73.34 | 70.34 | +3.23 | +4.61% | 2.47M | NYSE | |||
| 0.875 | 0.00 | 0.00 | +0.0703 | +8.74% | 6.48M | NYSE | |||
| 211.05 | 213.15 | 209.44 | +1.54 | +0.73% | 20.53M | NYSE | |||
| 115.00 | 115.90 | 96.01 | +11.64 | +11.26% | 4.92M | NASDAQ | |||
| 18.01 | 18.23 | 17.50 | +0.23 | +1.29% | 818.24K | NASDAQ | |||
| 42.09 | 42.33 | 40.39 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 8.13 | 8.167 | 7.91 | -0.120 | -1.45% | 4.68M | NASDAQ |
Universe Pharmaceuticals Inc is a holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, The Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments and cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. The Company mainly conducts its businesses within the China market.